Potent action of RFamide-related peptide-3 on pituitary gonadotropes indicative of a hypophysiotropic role in the negative regulation of gonadotropin secretion

  • Endocrinology. 2008 Nov;149(11):5811-21. doi: 10.1210/en.2008-0575.
Iain J Clarke  1 ,  Ika P Sari ,  Yue Qi ,  Jeremy T Smith ,  Helena C Parkington ,  Takayoshi Ubuka ,  Javed Iqbal ,  Qun Li ,  Alan Tilbrook ,  Kevin Morgan ,  Adam J Pawson ,  Kazuyoshi Tsutsui ,  Robert P Millar ,  George E Bentley
Affiliations
  • 1. Department Physiology, Building 13F, Monash University, Clayton Victoria 3800, Australia. [email protected]
Abstract

We identified a gene in the ovine hypothalamus encoding for RFamide-related peptide-3 (RFRP-3), and tested the hypothesis that this system produces a hypophysiotropic hormone that inhibits the function of pituitary gonadotropes. The RFRP-3 gene encodes for a peptide that appears identical to human RFRP-3 homolog. Using an antiserum raised against RFRP-3, cells were localized to the dorsomedial hypothalamic nucleus/paraventricular nucleus of the ovine brain and shown to project to the neurosecretory zone of the ovine median eminence, predicating a role for this peptide in the regulation of anterior pituitary gland function. Ovine RFRP-3 peptide was tested for biological activity in vitro and in vivo, and was shown to reduce LH and FSH secretion in a specific manner. RFRP-3 potently inhibited GnRH-stimulated mobilization of intracellular calcium in gonadotropes. These data indicate that RFRP-3 is a specific and potent mammalian gonadotropin-inhibiting hormone, and that it acts upon pituitary gonadotropes to reduce GnRH-stimulated gonadotropin secretion.

Products